BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 10639833)

  • 1. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE
    West Indian Med J; 1999 Dec; 48(4):173-8. PubMed ID: 10639833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The patho-epidemiology of benign proliferative epithelial disorders of the female breast.
    Cook MG; Rohan TE
    J Pathol; 1985 May; 146(1):1-15. PubMed ID: 3891937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Definition and development of "borderline" lesions in breast cancer. Atypical hyperplasia and carcinoma "in situ"].
    Contesso G
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):101-2. PubMed ID: 7451846
    [No Abstract]   [Full Text] [Related]  

  • 5. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for premalignant lesions in the human breast.
    Sloane JP
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():17-21. PubMed ID: 8298446
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathologic considerations in the high-risk breast patient.
    Simmons R; Serafin D; McCarty K
    Clin Plast Surg; 1988 Oct; 15(4):655-65. PubMed ID: 2852084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Benign and premalignant breast lesions--clinico-pathological correlation].
    Afek A; Shibi R; Kopolovitz G
    Harefuah; 1997 Nov; 133(9):375-8. PubMed ID: 9418343
    [No Abstract]   [Full Text] [Related]  

  • 10. Mucinous breast lesions: diagnostic challenges.
    Tan PH; Tse GM; Bay BH
    J Clin Pathol; 2008 Jan; 61(1):11-9. PubMed ID: 17873114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R; Kind M
    Gynakologe; 1989 Aug; 22(4):216-25. PubMed ID: 2676756
    [No Abstract]   [Full Text] [Related]  

  • 12. Premalignant disease: the breast.
    Vecchione L
    J Insur Med; 1999; 31(1):21-4. PubMed ID: 10539384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial dysplasia in nipple aspirates of breast fluid: association with family history and other breast cancer risk factors.
    Petrakis NL; Ernster VL; King EB; Sacks ST
    J Natl Cancer Inst; 1982 Jan; 68(1):9-13. PubMed ID: 6948129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diseases of the female breast: clinical pathology].
    Torhorst J
    Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Morphology, topography and growth pattern of benign proliferative breast lesions and pre-invasive cancers].
    Böcker W; Jarasch ED; Nagle EB; Höhne R
    Verh Dtsch Ges Pathol; 1985; 69():96-107. PubMed ID: 3006396
    [No Abstract]   [Full Text] [Related]  

  • 17. Triad of columnar cell alteration, lobular carcinoma in situ, and tubular carcinoma of the breast.
    Sahoo S; Recant WM
    Breast J; 2005; 11(2):140-2. PubMed ID: 15730461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.
    Masood S
    Clin Lab Med; 2005 Dec; 25(4):713-31, vi. PubMed ID: 16308088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign breast disease and cancer risk.
    Bianchi S; Palli D; Galli M; Zampi G
    Crit Rev Oncol Hematol; 1993 Dec; 15(3):221-42. PubMed ID: 8142058
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.